Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

Accounts Payable

$9.41M

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Accounts Payable

Latest reported$9.41Mperiod endingJun 30, 2026

Latest reported$9.41Mperiod endingJun 30, 2026

LGND Quarterly Accounts Payable ($1.00M → $9.41M)

Quarterly accounts payable

High-resolution chart · PNG

LGND accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2001	4,111,000
Mar 31, 2001	3,890,000
Dec 31, 2000	3,827,000
Sep 30, 2000	4,455,000
Jun 30, 2000	5,065,000
Mar 31, 2000	4,822,000
Dec 31, 1999	5,400,000
Sep 30, 1999	5,500,000
Jun 30, 1999	7,600,000
Mar 31, 1999	7,100,000
Dec 31, 1998	12,400,000
Sep 30, 1998	5,500,000
Jun 30, 1998	7,300,000
Mar 31, 1998	4,100,000
Dec 31, 1997	10,700,000
Sep 30, 1997	3,600,000
Jun 30, 1997	3,200,000
Mar 31, 1997	3,500,000
Dec 31, 1996	4,100,000
Sep 30, 1996	1,700,000
Jun 30, 1996	2,400,000
Mar 31, 1996	1,700,000
Dec 31, 1995	3,900,000
Sep 30, 1995	2,100,000
Mar 31, 1995	1,000,000
Dec 31, 1994	2,300,000
Sep 30, 1994	1,200,000
Jun 30, 1994	1,300,000
Mar 31, 1994	1,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.